Research ArticleExperimental Studies

Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma

NADEZHDA ROMANCHIKOVA and PETERIS TRAPENCIERIS
Anticancer Research August 2019, 39 (8) 4179-4184; DOI: https://doi.org/10.21873/anticanres.13577

Article Information

vol. 39 no. 8 4179-4184
DOI 
https://doi.org/10.21873/anticanres.13577
PMID 
31366503
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 24, 2019
  • Revision received June 20, 2019
  • Accepted June 24, 2019
  • Published online July 31, 2019.
Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. NADEZHDA ROMANCHIKOVA⇑ and
  2. PETERIS TRAPENCIERIS
  1. Latvian Institute of Organic Synthesis, Riga, Latvia
  1. Correspondence to: Nadezhda Romanchikova, Latvian Institute of Organic Synthesis, Aizkraukles Str. 21, LV-1006, Riga, Latvia. Tel: +371 66155119, Fax: +371 66155119, e-mail: nadezhda.romanchikova{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma
NADEZHDA ROMANCHIKOVA, PETERIS TRAPENCIERIS
Anticancer Research Aug 2019, 39 (8) 4179-4184; DOI: 10.21873/anticanres.13577
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords